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ABSTRACT
Basidiomycota are a large and diverse phylum of fungi. They can make
bioactive metabolites that are used or have inspired the synthesis of
antibiotics and agrochemicals. Terpenoids are the most abundant class
of natural products encountered in this taxon. Other natural product
classes have been described, including polyketides, peptides, and
indole alkaloids. The discovery and study of natural products made by
basidiomycete fungi has so far been hampered byseveral factors, which
include their slow growth and complex genome architecture. Recent
developments of tools for genome and metabolome studies are
allowing researchers to more easily tackle the secondary metabolome
of basidiomycete fungi. Inexpensive long-read whole-genome
sequencing enables the assembly of high-quality genomes, improving
the scaffold upon which natural product gene clusters can be predicted.
CRISPR/Cas9-based engineering of basidiomycete fungi has been
described and will have an important role in linking natural products to
their genetic determinants. Platforms for the heterologous expression of
basidiomycete genes and gene clusters havebeen developed, enabling
natural product biosynthesis studies. Molecular network analyses and
publicly available natural product databases facilitate data dereplication
and natural product characterisation. These technological advances
combined are prompting a revived interest in natural product discovery
from basidiomycete fungi.
This article has an associated Future Leader toWatch interview with the
first author of the paper.
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Introduction
Natural products (NPs) are low-molecular weight molecules that are
made by living organisms and are often referred to as secondary
metabolites. This is because, despite offering a competitive
advantage to the producing organism, they are not essential for its
survival. NPs are used by humankind for many applications,
including as drugs; NPs and NP derivatives represent 25% of new
anticancer and 55% of new antibacterial drugs approved by the US
Food and Drug Administration (FDA) between 1981 and 2019
(Newman and Cragg, 2020). Historically, selected groups of
organisms have been the main focus for NP discovery; one such
group of organisms is actinomycete bacteria, from which a variety of
bioactive NPs (Fig. 1A) have been employed in modern human
and veterinary medicine, and agriculture. These NPs include the
antibiotic daptomycin, isolated from Streptomyces roseosporus
(Debono et al., 1988); and anthelmintic agents avermectins, derived
from Streptomyces avermitilis (Miller et al., 1979). Gram-negative
bacteria are another important reservoir for NPs of varying
bioactivities, including antibiotics, such as teixobactin (Fig. 1A),
found in the recently discovered Eleftheria terrae (Ling et al., 2015).
Plants represent another large source of NPs (Fig. 1B), including the
antimalarial artemisinin, found in Artemisia annua (Klayman et al.,
1984); and anticancer agent paclitaxel, marketed as Taxol, discovered
in Taxus brevifolia (Rowinsky and Donehower, 1995).
Fungi are also a rich source of NPs, with NP discovery primarily
focusing on species belonging to the phylum Ascomycota thus far.
Various NPs from ascomycete fungi hold prominent roles in our
daily lives (Fig. 1C), including β-lactam antimicrobials such as
penicillin (Fleming, 1929) and cephalosporins (Abraham et al.,
1953), originally discovered in Penicillium rubens and Acremonium
strictum, respectively; and immunosuppressant cyclosporine, made
by Tolypocladium inflatum (Kahan, 1989). Fungi of the phylum
Basidiomycota represent a rich source of NPs, often overlooked for
several key reasons, such as their large and complex genome
structures, as well as being difficult to work with, as a consequence
of their slow growth rate compared with other fungi and bacteria.
Due to this, secondary metabolite study has lagged behind in
basidiomycete fungi. With the release of an increasing number of
whole-genome sequences (at present, more than 540 basidiomycete
genomes are accessible from the web portal of the US Department
of Energy Joint Genome Institute), as well as their antiquity in
traditional medicine and culinary usage, the interest in the study of
NPs in basidiomycete fungi has grown considerably in recent years.
As commonly seen in other microorganisms, and to some extent
in plants, the genes that code for fungal NP biosynthetic enzymes
are often clustered together on the same genomic region, a feature
that allows researchers to more easily mine the genetic determinants
of NP biosynthesis (Osbourn, 2010). Biosynthetic gene clusters can
include genes coding for synthase enzymes, tailoring enzymes and
transcriptional regulators (Medema et al., 2015).
Basidiomycete fungi and their NPs
Fungi belonging to the phylum Basidiomycota can produce NPs
that belong to several different biosynthetic classes (Lin et al.,
2019), including terpenoids, polyketides, non-ribosomal peptides,
ribosomally synthesised and post-translationally modified peptides,
and indole alkaloids. Each class of NPs are structurally diverse
and encompass their own biosynthetic enzymatic machinery and
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tailoring enzymes. Interclass differences may also be vast, with
individual metabolites varying in structure, bioactivity, and size.
Terpenoids
Terpenoids (Fig. 2A) are the most abundant and diverse class of NPs
produced by basidiomycete fungi (Schmidt-Dannert, 2015), and are
found in many other organisms, including plant and bacterial species.
These NPs have a broad spectrum of bioactivities; some examples of
terpenoids include: ganoderic acid β, one of several analogues of
ganoderic acid made by Ganoderma lucidum, with this particular
analogue possessing antiviral bioactivity (Min et al., 1998); illudin-S
and illudin-M are two sesquiterpenoids with antitumour and antibiotic
bioactivity, and are believed to be responsible for the toxicity of the
jack-o’-lantern mushroom Omphalotus illudens (McMorris and
Anchel, 1965); and antifungal sterelactones isolated from a Stereum
sp. (Opatz et al., 2008). A particularly important example of a
bioactive terpenoid made by basidiomycete fungi is that of the
antibiotic pleuromutilin, a diterpene antibacterial NP, initially
discovered in the two fungi Pleurotus mutilus (synonymous to
Clitopilus scyphoides f. mutilus) and Pleurotus passeckerianus
(synonymous to Clitopilus passeckerianus) during the golden age of
antibiotic discovery (Kavanagh et al., 1949). Pleuromutilin mediates
its antibacterial bioactivity by inhibition of protein synthesis through
selective binding at the peptidyl transferase centre, at the A- and
P-sites of the ribosome (Davidovich et al., 2007). Since its discovery,
semi-synthetic derivatives tiamulin and valnemulin have been
employed in veterinary use, and retapamulin is utilised as a topical
antibiotic in humans (Daum et al., 2007; Poulsen et al., 2001). More
Fig. 1. Structures of NPs mentioned in this article produced by organisms other than basidiomycete fungi. (A) Bacterial, (B) plant, and
(C) ascomycete NPs.
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recently, lefamulin has been granted permission by the US FDA for
use in the treatment of community-acquired bacterial pneumonia,
becoming the first ever antibiotic derived from basidiomycete fungi to
be approved for systemic use in humans (Watkins and File, 2020).
Terpenoids all consist of several isoprene units, however,
diversification in structure can be achieved by differences in
linearity or cyclicity, saturated or unsaturated bonds, and other
modifications, such as reduction, decarboxylation, glycosylation,
Fig. 2. Structures of NPs mentioned in
this article produced by basidiomycete
fungi. (A) Terpenoids, (B) polyketides,
(C) non-ribosomal peptides, (D) RiPPs,
(E) indole alkaloids.
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alkylation, and acetylation, to name a few. For details on the
biosynthesis of fungal terpenoids we refer the reader to other
reviews on this topic (Hoffmeister and Keller, 2007; Schmidt-
Dannert, 2015).
Polyketides (PKs)
PKs are known to be highly abundant in fungi, with research
primarily focusing on ascomycete fungi thus far. Despite this, known
PKs of basidiomycete fungi are structurally and functionally diverse
(Fig. 2B). Some examples of PKs produced by fungi of the phylum
Basidiomycota include the antioxidant anthraquinone-related
pigments, such as rufoolivacins, isolated from Cortinarius
purpurascens (Bai et al., 2013; Gao et al., 2010); oudemansin,
an antifungal antibiotic isolated from Oudemansiella mucida (Anke
et al., 1979); mycotoxins aurovertin B and E from Albatrellus
confluens (Wang et al., 2005); and lovastatin, an HMG-CoA
reductase inhibitor used as a cholesterol lowering agent and found
in the oyster mushroom, Pleurotus ostreatus (Atli and Yamac, 2012).
Strobilurin A is an antifungal PK, first isolated from Strobilurus
tenacellus (Steglich and Schramm, 1977). Strobilurin A mediates a
fungicidal effect by selective targeting of the β-methoxyacrylate
toxophore to complex III of the mitochondrial electron transport
chain, inhibiting adenosine triphosphate synthesis (Becker et al.,
1981). Since its discovery, derivatives of strobilurin A based on the
β-methoxyacrylate moiety have been developed for use as
agricultural fungicides, including the highest-selling fungicide
azoxystrobin (Bartlett et al., 2002; Sauter et al., 1999). Strobilurin
fungicides are estimated to have a market value of $3.4 billion, which
corresponds to 25% of the overall global market of fungicides
(Nofiani et al., 2018).
Most fungal PKs are synthesised by iterative multidomain type I
polyketide synthase (PKS) enzymes, which are similar to fatty acid
synthases (FASs), however some examples of type III PKSs are also
known, which include a single ketosynthase domain (Seshime et al.,
2005). For an overview of the biosynthetic mechanism of fungal
PKs we refer the reader to other reviews on this topic (Cox, 2007;
Hoffmeister and Keller, 2007).
Non-ribosomal peptides (NRPs)
NRPs are a class of NPs largely underrepresented in basidiomycete
studies (Fig. 2C), with research on these secondary metabolites
being primarily focused on ascomycete fungi. Some NRPs found
in fungi of the phylum Basidiomycota include ferrichrome and
ferrichrome A, siderophores produced by Ustilago maydis
(Winterberg et al., 2010; Yuan et al., 2001); and involutin, an
Fe3+ reductant isolated from the ectomycorrhizal Paxillus
involutus (Shah et al., 2015).
Fungal NRPs are synthesised by multimodular NRP synthetase
(NRPS) enzymes, using either proteinogenic or non-proteinogenic
amino acids to construct the NP (Vassaux et al., 2019).
Ribosomally synthesised and post-translationally modified peptides
(RiPPs)
Peptide NPs can be synthesised by two mechanisms. One is by the
previously mentioned NRPSs, and another is ribosomally-driven
synthesis. Unlike NRP synthesis, ribosomal biosynthesis requires
the translation of a precursor peptide which must then be post-
translationally modified, yielding the mature peptide. Fungal RiPPs
(Fig. 2D) are relatively newly discovered, with the first family
described in 2007 (Hallen et al., 2007). α-amanitin, isolated from
Amanita bisporigera, is a ribosomally-synthesised amatoxin with a
bicyclic octapeptide structure, and is the lethal constituent of this
poisonousmushroom, exerting a toxic effect by selective inhibition of
RNA polymerase II and consequently halting mRNA synthesis
(Chafin et al., 1995). Omphalotin A is a potent nematicidal
cyclic dodecapeptide isolated from the jack-o’-lantern mushroom
O. olearius (Mayer et al., 1997). Until recently, omphalotin A was
considered to be a product of NRPSs, however it has since been
shown that incorporation of α-N-methylation of the peptide backbone
occurs via the RiPP pathway (Ramm et al., 2017; van der Velden
et al., 2017).
Commonly between RiPPs and other NPs is that their biosynthetic
pathways are encoded by gene clusters. For an overview of RiPP
biosynthesis in fungi and common post-translational modifications,
we refer the reader to another recent review (Vogt and Künzler,
2019).
Indole alkaloids
Indole alkaloids are one of the largest classes of nitrogen-containing
secondary metabolites and are found across all kingdoms of life,
however, fungi, particularly ascomycetes, are reportedly prolific
producers of these NPs. Indole alkaloids are also well known in
basidiomycete fungi (Fig. 2E), for example norharmane and
harmane, tremorgenic neurotoxins isolated from the ivory waxy
cap Hygrophorus eburneus (Teichert et al., 2008); dimeric
pyrroloquinolines mycenarubin A and mycenarubin B are red
pigments isolated from Mycena rosea (Peters and Spiteller, 2007);
and acetylcholinesterase inhibitors infractopicrin and 10-
hydroxyinfractopicrin isolated from Cortinarius infractus (Geissler
et al., 2010). Psilocybe mushrooms have long been known for their
use in both medicinal and religious practices (Andersson et al., 2008).
Psilocybin and psilocin, the hallucinogenic alkaloids, were first
identified in Psilocybe mushrooms in 1958, and shown to have
profound psychotropic effects, similar to those induced by lysergic
acid diethylamide (Hofmann et al., 1958). Psilocybin is a prodrug that
rapidly dephosphorylates, forming the psychoactive, hallucinogenic
psilocin. In humans, this dephosphorylation occurs in the liver, likely
by first-pass metabolism, allowing psilocin to act as a high-affinity
partial agonist for 5-HT2A receptors in the central nervous system.
Indole alkaloids are generally derived from tryptophan, which is
derived from the shikimic acid pathway, and dimethylallyl
pyrophosphate, from the mevalonate pathway whose products
also act as the precursor units for terpenoids. Though tryptophan is
commonly used as an amino acid precursor, amino acids other than
tryptophan, such as tryptamine, are known to be used in indole
alkaloid biosynthesis (Xu et al., 2014).
Recent advances in tools for the study of basidiomycete NPs
Long-read whole-genome sequencing
Fungi belonging to the phylum Basidiomycota have an average
genome size of 46 Mb (Mohanta and Bae, 2015). As a comparison,
fungi of the phylumAscomycota have an average genome size of 37
Mb (Mohanta and Bae, 2015), whereas the genomes of Archaea and
Bacteria normally fall within 6 Mb (Kellner et al., 2018). This
means that while bacterial genomes can be sequenced using
short-read sequencing, accurate genome assembly in fungi requires
long-read sequencing. This can be achieved in different ways,
such as through the inexpensive nanopore sequencing (Dreamer
et al., 2016). Indeed, nanopore whole-genome sequencing of
basidiomycete isolates has been reported; for instance, the 54 Mb-
genome of the plant pathogen Rhizoctonia solani was successfully
sequenced throughMinION and assembled into 606 contigs with an
N50 of 199 Kb (Datema et al., 2016 preprint). More recently,
MinION was used to identify all taxa present in a mock fungal
4









 by guest on December 8, 2020http://bio.biologists.org/Downloaded from 
community, including basidiomycete isolates, indicating that it may
be employed to profile fungal communities (Mafune et al., 2019).
Despite the increased read length and reduced cost of nanopore
long-read sequencing, the accuracy of base calling – 85–94%
depending on the sequencing method (Jain et al., 2017) – and lower
throughput than the established short-read platforms such as Illumina
are an issue. However, when nanopore long-read sequencing is
utilised in conjunction with short-read sequencing it is possible to
assemble genomes of higher quality than either can provide
independently. The quality of genomes assembled using a hybrid
of long and short reads will only improve as the software for
assembling these genomes also advances, for example Pilon now
contains a function that will incorporate both Illumina and nanopore
sequence data when polishing assemblies; while these software
packages often focus on bacterial genomes, there is no doubt robust
programs focussing on fungal genomes will soon follow (Goldstein
et al., 2019), and multiple high-quality fungal genomes have already
been sequenced using one flow cell in a MinION (McKenzie et al.,
2020). Most de novo genome assembly programs today still utilise de
Bruijn graph-based methods. This method is inappropriate for the
quantity of indels and error rates produced by long-read sequencers
today, therefore a return to the overlap-consensus method will likely
improve the quality of assemblies made using long-read sequencing
data. This has already been proven for bacteria, where an Escherichia
coli genome purely assembled from nanopore sequencing data was
used to create a single contig genomewith 99.5% base accuracy using
the ‘nanocorrect’ and ‘nanopolish’ pipeline (Loman et al., 2015).
Furthermore long-read whole-genome sequencing techniques can
detect base modifications, with the nanopore able to recognise all five
C5-cytosine variants (Wescoe et al., 2014). It can detect endogenous
and exogenous RNA modifications (Stephenson et al., 2020
preprint). Long-read sequencing is also unparalleled for examining
metagenomic data, with recent studies assembling over 1000
high quality genomes from metagenomic samples run on the
PromethION (Singleton et al., 2020 preprint). As nanopore
technology matures we will likely see the accuracy of reads
increase to be as competitive as short-read sequencing, recent
advances have utilised neural networks within the base calling
software to reach 97.7% accuracy (Silvestre-Ryan and Holmes, 2020
preprint), and further improvements to the hardware and software are
likely in the coming years. It should also be noted that in the future,
nanopore technologywill not just be capable of long-read sequencing
RNA and DNA, but will also be capable of sequencing proteins
(Ouldali et al., 2020). Long-read sequencing of proteins will no doubt
prove invaluable to groups searching for the biosynthetic pathways
responsible for producing NPs.
CRISPR/Cas9-mediated engineering of basidiomycete fungi
It has long been known that genetically transforming targets is
a vital tool for detailed molecular analysis, and until recently it
was exceptionally difficult to do this in basidiomycete fungi.
Gene disruption, for example, has until recently, only been
achieved using homologous recombination with a low efficiency
(Ohm et al., 2010). However, protocols utilising CRISPR/Cas9
have now been developed for selected basidiomycete fungi
(Table 1).
However, basidiomycete utilisation of CRISPR/Cas9 is more
complex than working with bacteria, as Cas9 must be both codon-
optimised and have a nuclear localisation signal attached. CRISPR/
Cas9 systems have a multitude of advantages over other techniques,
for example, target sites need only have a PAM sequence, which
makes almost every gene a valid target. Compared with techniques
such as transcription activator-like effector nucleases (TALEN)
and zinc finger nucleases (ZFN), CRISPR/Cas9 is faster, more
precise and versatile (Deng et al., 2017). Furthermore, it is viable for
multiple simultaneous gene edits, making a dearth of selection
markers less problematic. Most importantly, is the simplicity of
components required, synthetic guide (sg)RNA and Cas9 being the
major parts.
The breakthrough of CRISPR/Cas9 in basidiomycete fungi
happened in 2016, when it was announced that Yinong Yang and
collaborators used this technique to remove one of the genes that
encodes polyphenol oxidase in Agaricus bisporus, slowing down
the process of browning and increasing the shelf life of the button
mushroom (Waltz, 2016). Despite the achievement being covered in
news articles, the CRISPR/Cas9 method used by the Yang group to
engineer A. bisporus has not been published. The following year a
CRISPR/Cas9-based editing protocol was published forG. lucidum
and Ganoderma lingzhi (Qin et al., 2017). The authors achieved
disruption of the ura3 gene in these fungi through CRISPR/Cas9-
guided double stranded break, followed by repair through non-
homologous end joining (NHEJ), which resulted in short insertions
and deletions at the target sites. In the same year CRISPR/Cas9 was
used to form the basis of a high-throughput transformation
technique, which successfully inserted luciferase and GFP into
Coprinopsis cinerea to assess constitutive promoters; the authors
also developed an improved way of cryopreserving protoplasts
(Sugano et al., 2017). Despite these successes, targeting efficiency
remained low, potentially due to inefficient sgRNA and/or Cas9
expression (Sugano et al., 2017); however, the gates of CRISPR/
Cas9 for engineering and editing fungi of the phylum
Basidiomycota were opened. A potential solution to this
bottleneck has been provided in other fungi by utilising tRNA
promoters to drive transcription of sgRNA. This was successfully
performed on the ascomycete fungus Aspergillus niger, and where
the Cas9 and sgRNA were on the same plasmid, this created gene
mutations with an efficiency of ∼97% (Song et al., 2018). Once
CRISPR/Cas9 was shown as a viable choice for the engineering of
basidiomycete fungi it did not take long for a multitude of fresh
techniques and improvements which expand the scope and increase
the efficiency of CRISPR/Cas9 to be developed. For example,
Schizophyllum commune has been successfully used to demonstrate
pre-assembled Cas9-sgRNA ribonucleoproteins for use in gene
deletion; the sgRNA, Cas9, and a repair template, were all inserted
into protoplasts using PEG-mediated transformation, removing the
need to optimise sgRNA and Cas9 expression within the host (Jan
Vonk et al., 2019). Recombination events were selected for by the
inclusion of a selectable marker cassette within the repair template.
This technique is best described as CRISPR/Cas9 mediated
homology-directed repair (HDR): a technique in which a double
stranded break is repaired by providing a homologous DNA
fragment. It can be used for the precise disruption of genes and
insertion of selectable markers or other sequences of interest. The
authors showed that homology arms of 250 bp were sufficient to
efficiently induce the target gene replacement with a selectable
marker cassette. Similarly, protoplasts of the basidiomycete yeast
Pseudozyma antarctica have been efficiently transformed and had
targeted genes disrupted via incubation with a ribonucleoprotein
complex, consisting of the Cas9 protein and a single sgRNA with
donor DNA containing a selectable marker (Kunitake et al., 2019).
The authors showed that increasing the volume of the
ribonucleoprotein mix increased transformation efficiencies, and
that having homology arms of over 100 bp was best practice for
inducing efficient homologous recombination with this system,
5
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although homology arms were shown to not actually be required to
insert the donor DNA into the target locus. Ustilago maydis is
another model organism that has recently seen successful CRISPR/
Cas9-based multiplex gene editing, in which five genes coding for
virulence-promoting secreted effectors were successfully
inactivated using a single CRISPR plasmid (Schuster et al.,
2018). Multiplexing is an important function for gene disruption
in fungal pathways as usually biosynthetic routes are controlled by
multiple genes and it is desirable to generate simultaneous
knockouts. The capability of CRISPR/Cas9 systems to perform
multiple simultaneous gene knockouts is where great potential lies.
The previous techniques utilising ZFN and TALEN are laborious,
and limited in scope in comparison, and we are seeing more
multiplexing being performed in fungi of the phylum
Basidiomycota now that the technology is maturing. For example,
Rhodosporidium toruloides has been successfully multiplexed with
CRISPR/Cas9 to disrupt the car2 and ura3 genes in a single
transformation, and single transformations reached up to 50%
efficiencies (Otoupal et al., 2019). Additional CRISPR/Cas9
platforms for successfully editing the NP-producer G. lucidum
have recently been established (Liu et al., 2020;Wang et al., 2020a).
Interestingly, it has been shown that by introducing an intron
upstream of the cas9 gene, it is possible to drastically increase
efficiency of transformations by over ten times the rates seen
without the intron, arriving at a final gene deletion rate of 36.7%
(Liu et al., 2020). The inclusion of an intron before the start of the
coding sequence is an established approach that has been shown to
be necessary to achieve heterologous gene expression in several
basidiomycete fungi, such as C. cinerea, A. bisporus (Burns et al.,
2005) and Armillaria mellea (Ford et al., 2016).
As it stands, the problem of CRISPR in basidiomycete fungi is not
just a case of low efficiency rates and lack of platforms and support,
which are being overcome as shown above, but of off-target effects,
screening and selection issues, continued genome modification after
the error gene is repaired, and NHEJ indel size variation leading to
frameshifts that cannot be controlled. Techniques have been
developed to inhibit native NHEJ by using small molecules, like
Scr7, allowing the HDR presented in templates we insert to dominate
(Maruyama et al., 2015). Techniques such as this will continue to be
developed and will eventually cross over not just into fungi but
specifically into basidiomycete strains. A new method called
PEM-seq has been developed that has high sensitivity and uses
high-throughput sequencing; it can identify off-target sites of Cas9
and quantify the cutting efficiency of CRISPR/Cas9 at the target site,
therefore, it can be used to find more efficient Cas9 cutting sites (Yin
et al., 2019). This technique is not established in fungi of the phylum
Basidiomycota yet, but it or technology like it are likely to arrive. As
CRISPR/Cas9 matures we will see more and more basidiomycete-
based platforms for high-throughput, rapid genome engineering. And
no doubt as improvements and novel uses for CRISPR/Cas9 are
discovered in other organisms and particularly other fungi, these
changes too will eventually make their way to basidiomycete-based
application. For example, a plasmid containing the Aspergillus
nidulans AMA1 sequence (Gems et al., 1991) has been generated for
use in Aspergillus oryzae, which improves efficiency by being
multi-copy, causing an increase in Cas9 and sgRNA, but a quirk of
the AMA1-based plasmids is that they are discarded from the cells
after several rounds of non-selective subculturing, theoretically
making it possible to have infinite rounds of genetic engineering
(Katayama et al., 2019). This will help to not just study biosynthetic
pathways of NPs but also to generate fungal strains that have
industrial application.
Platforms for heterologous expression of basidiomycete gene cluster
While working on the NP producing basidiomycete itself is a
powerful tool, once putative biosynthetic genes have been identified,
few techniques are as powerful as insertion of these genes into
heterologous hosts. Furthermore, while the NPs of basidiomycete
fungi may be of medical and industrial interest, the fungi themselves
are often not appropriate for generating industrial quantities of the NP
due to their slow growth, furthering the need for robust platforms for
heterologous expression of biosynthetic pathways within fast-
growing organisms better suited to the rigours of industry.
Escherichia coli is the well-established workhorse of the
biotechnology world, so it should come as no surprise that
basidiomycete NPs have been produced within this organism. The
appeal is obvious, it is a unicellular, well understood and very fast-
growing organism, and robust techniques and tools for its
manipulation are available. Examples of its use include, the
heterologous expression of sesquiterpene synthases from
Coniophora puteana for use in generating β-copaene and cubebol,
which were then used to create a heterologous microbial production
system, with yields that exceeded all previously published results for
these compounds (Mischko et al., 2018). The unspecific peroxygenase
MroUPO from the basidiomyceteMarasmius rotulawas expressed in
E. coli alongside computationally guided mutated variants for the
purposes of optimising the enzyme (Carro et al., 2019). Cytochrome
P450s from the basidiomycete Phanerochaete chrysosporium were
expressed using the T7 RNA polymerase/promoter system in E. coli
and subsequently optimised bymodifying their N-terminal amino acid
sequences, and their mechanisms of function elucidated (Hatakeyama
et al., 2016). Escherichia coli was used to functionally characterise,
through heterologous expression, putative sesquiterpene synthases
from Omphalotus olearius (Wawrzyn et al., 2013). However, for
expression of more complex proteins and entire biosynthetic pathways,
E. coli is not appropriate, not just because the genes are not codon
optimised for this organism, or because the systems for required
post-translational modifications are not usually present, but because
secondary metabolite excretion is not developed and because many of
the useful NPs produced by basidiomycete fungi carry antibiotic
properties, to which E. coli is susceptible.
Because of the limitations posed by E. coli, it is natural for
researchers to look for a fungal substitute that retains the benefits of
being a well-understood, generally recognised as safe to work with,
fast growing, unicellular, model organism, with a plethora of cost
efficient tools and techniques for transformation such as a golden
gate toolkit (Lee et al., 2015). Yeasts fulfil all these roles and have a
long history of industrial application making them simple to culture
in bioreactors. Among yeasts, Saccharomyces cerevisiae has been
used to study enzymes from basidiomycete fungi. For instance,
three sesquiterpene synthase genes from the medicinal mushroom
Lignosus rhinocerotis were identified using genome mining and
transcriptomics, and were heterologously expressed in S. cerevisiae
to give sesquiterpene alcohols (Yap et al., 2017). Many S. cerevisiae
strains exist today which overproduce the precursor compounds
utilised for biosynthesis of secondary metabolites, for example
S. cerevisiae EPY300 overexpresses the mevalonate pathway, and
can be exploited to produce terpenoids in large amounts (Ro et al.,
2006). The more recently developed S. cerevisiae EPYFA3, which
is derived from EPY300, overexpresses both the mevalonate and
the shikimate pathways and is shown to be able to overproduce
isoprenoid quinones (Kaur et al., 2020). Pichia pastoris is another
popular yeast to work with, and the minor laccase isozymes
Lac2 and Lac3 from the basidiomycete Grifola frondosa were
heterologously expressed and characterised using this yeast
7
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(Nitheranont et al., 2017). Pichia pastoris was also used to
heterologously express a further nine laccases from Cerrena sp.
(Yang et al., 2015, 2016). Yeasts are also a good choice for
heterologous expression because directed evolution can be used to
rapidly optimise expression of a secondary metabolite from
heterologous hosts. Compared to bacteria, which can also be used
to perform directed evolution, yeasts are more likely to correctly
express and secrete basidiomycete proteins, therefore enabling for
in-host screening of the effects of directed evolution. For example,
the unspecific peroxygenase from Agrocybe aegerita was
engineered through directed evolution in S. cerevisiae to improve
its catalytic attributes, and the resulting evolved unspecific
peroxygenase was then inserted into P. pastoris to obtain a
27-fold increase in production levels (Molina-Espeja et al., 2015).
Despite some successful examples of using S. cerevisiae to
express basidiomycete genes, this host is not always able to
correctly express entire basidiomycete gene clusters. A recent study
showed that only 7/17 (41%) basidiomycete gene clusters were
productive when expressed in S. cerevisiae, as opposed to 17/26
(65%) ascomycete clusters (Harvey et al., 2018). Potential reasons
may include the inability of S. cerevisiae to process the numerous
introns found in basidiomycete genes. Indeed, fungi of the phylum
Basidiomycota are known to be generally richer in introns than
other fungi, with basidiomycete fungi showing 5.28 exons per gene
while ascomycete fungi have only 2.58. Among fungi of the phylum
Ascomycota, S. cerevisiae has only 1.04 exons per gene (Goffeau
et al., 1996), while A. oryzae has 2.98 (Arnaud et al., 2011). Indeed,
a recent study led by Oikawa’s group showed that A. oryzae is able
to remove 87% of the introns from basidiomycete terpene synthase
genes (Nagamine et al., 2019). The same group used this host to
study the biosynthesis of the diterpene erinacine, where 90% of
introns were correctly spliced out by A. oryzae and the remaining
introns were removed by PCR prior to achieving correct expression
(Liu et al., 2019). Aspergillus oryzae has been successfully used in a
number of studies to recreate and characterise basidiomycete NP
pathways, such as those for pleuromutilin (Alberti et al., 2017a;
Bailey et al., 2016; Yamane et al., 2017) and strobilurin (Nofiani
et al., 2018), in which introns were removed prior to heterologous
expression.
Among fungi of the phylum Basidiomycota, the corn smut
U. maydis has recently been developed into a heterologous host for
the production of terpenoids through the overexpression of
endogenous mevalonate pathway genes (Lee et al., 2020). The
chassis was validated through the heterologous expression of fungal
and plant sesquiterpenoid synthases fromC. cinerea and the Nootka
cypress Callitropsis nootkatensis, respectively.
Often the best results for functional characterisation can be
obtained by combining multiple heterologous systems into one
study such as when six sesquiterpene synthases from C. cinerea
were expressed in E. coli and S. cerevisiae (Agger et al., 2009).
Molecular network analysis
The successful characterisation of basidiomycete NPs and their
biosynthesis not only requires molecular biology tools for genetic
engineering and heterologous expression, but also relies upon
metabolic analyses (van der Hooft et al., 2020). Traditional
bioactivity-guided fractionation of metabolite extracts has now
been overtaken by more sensitive approaches, such as untargeted
metabolomics and data analysis of tandem mass-spectrometry (MS/
MS). MS/MS spectra result from the fragmentation of metabolites
and constitute the fingerprint of a given compound. Oncemetabolite
extracts have been generated and analysed throughMS/MS, one can
compare the data with spectral libraries. However, these libraries are
still far from comprehensive. For instance, the Global Natural
Product Social molecular networking (GNPS) site contains MS/MS
reference spectra for only 2.5% of known NPs (van der Hooft et al.,
2020). A parallel approach that can aid data dereplication and
identification of unknown metabolites, as well as to link pathway
intermediates, shunt and final products to each other, relies on the
use of software that can group metabolites based on similarities in
their MS/MS fragmentation patterns. GNPS (Wang et al., 2016) has
been used by many NP researchers for this purpose, including for
fungi of the phylum Basidiomycota. For instance, molecular
network analysis enabled the discovery of two bioactive xylosides
from co-cultures of the basidiomycete fungi Trametes versicolor
and Ganoderma applanatum (Yao et al., 2016). In this study, a
useful feature of molecular network analysis was highlighted when
sub-structure predictions were made based on the grouping of
metabolites that differ in mass by values equivalent to pentose
moieties, suggesting that glycosylation would take place. A follow-
up study by the same group investigated the origin of the
metabolites that were induced by co-cultures of the two fungi to
link them to the respective producing organism (Xu et al., 2018).
The authors combined 13C-based labelling and molecular network
analyses to show that 31 out of 74 induced features were being
produced by either T. versicolor orG. applanatum, or by both fungi.
Importantly, the origin of the induced metabolite could be discerned
even when the structure of the molecule in question was unknown.
This approach could be applied to other co-culture studies and aid
the identification of cryptic NP gene clusters.
New features are frequently being added to the GNPS suite, such
as the MS2LDA tool, which identifies sub-structures within a
metabolite structure through the unsupervised detection of co-
occurring molecular fragments, inspired by text-mining (van der
Hooft et al., 2016). This tool enables users to annotate molecules
for which no reference spectra can be found and helps reveal
biochemical relationships between compounds. Another newly
added feature to the GNPS platform is the Mass Spectrometry
Search Tool (MASST), which allows researchers to perform MS
searches (Wang et al., 2020b). With this tool, all public data
available in GNPS can be searched using an MS/MS spectrum as a
query, in a similar manner to searches using nucleotide and amino
acid sequences through the popular Basic Local Alignment Search
Tool (BLAST) (Altschul et al., 1990).
Future prospects
In the last five years, recently developed technologies for genome
sequencing and genetic engineering have been applied to
basidiomycete fungi, including nanopore sequencing for the
generation of long-read genome assemblies and CRISPR/Cas9-
based editing. Future prospects will likely include the improvement
of genetic engineering tools, for instance through the wider
implementation of HDR via a repair template in the CRISPR/
Cas9 basidiomycete toolkits. HDR promotes a more precise gene
editing compared to NHEJ, with the latter causing insertions or
deletions of various length, which can lead to a shift of the open
reading frame. However, HDR is generally less efficient than NHEJ,
and the inclusion of repair arms does not guarantee that it will take
place. Ways of improving the efficiency of HDR in basidiomycete
CRISPR/Cas9 endeavours may include the inhibition of enzymes
involved in the NHEJ pathway. This approach was used to increase
the efficiency of HDR genome editing in mice and mammalian cell
lines by up to 19-fold by targeting DNA ligase IV using the
inhibitor Scr7 (Maruyama et al., 2015). An alternative to canonical
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double-stranded break-mediated CRISPR/Cas9 editing can be
found in base editing (Komor et al., 2016). This involves the use
of a catalytically dead Cas9 and a cytidine or adenosine deaminase,
which enable for base-editing without needing to cause double-
stranded breaks in the target or to introduce a repair template.
Successful CRISPR/Cas9-mediated base editing has recently been
reported in filamentous ascomycetes (Huang et al., 2019).
Techniques such as these will continue to be developed and will
eventually cross over into basidiomycetes.
Besides the engineering of a NP-producing basidiomycete strain,
heterologous expression of a candidate NP gene cluster is an
established and effective approach to link specialised metabolites to
their genetic determinants, discover new bioactive molecules and
characterise their biosynthesis (Alberti et al., 2017b). The successful
heterologous expression of basidiomycete clusters has been described
in several hosts, including S. cerevisiae (Harvey et al., 2018) and,
despite the reported incomplete intron-splicing, in A. oryzae
(Nagamine et al., 2019). Ascomycete hosts are easier to transform
and engineer than basidiomycete fungi, therefore they are the
preferred chassis for the study of basidiomycete NP gene clusters.
However, a first step toward the use of U. maydis has been achieved
recently when its mevalonate pathway was overexpressed, and the
resulting strain was used to express fungal and plant sesquiterpenoid
synthases (Lee et al., 2020). Expression of entire biosynthetic gene
clusters will likely follow in this host. Other model basidiomycete
fungi that may be developed into heterologous hosts for the study of
NPs include C. cinerea and A. bisporus, which, unlike U. maydis,
benefit from not being plant pathogenic. Molecular toolkits (Burns
et al., 2005; Collins et al., 2010) have been established for these two
mushroom-forming species, followed by the development of
CRISPR/Cas9-based engineering tools (Sugano et al., 2017; Waltz,
2016), and will likely be expanded and employed in the near future to
aid the study of NPs made by other fungi of the phylum
Basidiomycota. The establishment of a basidiomycete heterologous
host means that genes of interest could be amplified from the genomic
DNA of donor basidiomycete strain, or even be obtained as synthetic
DNA, without having to embark in the laborious task of predicting
and removing their numerous introns.
On the front of metabolic analyses, publicly available NP databases
(e.g. The Natural Product Atlas; van Santen et al., 2019) and
molecular network analysis (e.g. GNPS; Wang et al., 2016) represent
valuable tools for data dereplication and NP characterisation. The in-
silico prediction of NP structures based on gene sequences is a task
that still requires refinement. Tools such as antiSMASH (Blin et al.,
2019) and PRISM (Skinnider et al., 2017) can predict the sequence of
monomers that are assembled into PKS and NRPS biosynthetic lines
based on module specificity. However, the accurate prediction of a
cyclisedNP structure, as well as of the functionalisation of the core NP
through tailoring reactions, still remain challenging. Future efforts are
envisaged to take place that will aim to improve such predictions by
training machine learning models to link genetic and metabolic data.
Concluding remarks
Fungi belonging to the phylum Basidiomycota have shown the
potential to produce bioactive metabolites that have been exploited
commercially, including as antimicrobials (such as pleuromutilin
antibiotics) and agrochemicals (such as strobilurin fungicides).
Recent advances of molecular tools for the study of basidiomycete
fungi are allowing researchers to explore this prolific microbial taxon
further. Future endeavours will be necessary to improve themolecular
toolbox available for the engineering of basidiomycete fungi. These,
coupled with efficient and reliable transformation protocols, will
likely lead to the development of a true basidiomycete heterologous
host that can be employed to discover NPs from cryptic gene clusters
and characterise their biosynthesis. Further efforts are also needed to
improve the prediction of NP structures starting from genetic
information, in order to navigate the vast number of whole-genome
and metagenome sequences that are currently being generated and
prioritise gene clusters for experimental characterisation.
Competing interests
The authors declare no competing or financial interests.
Funding
The authors would like to acknowledge funding from the Leverhulme Trust [ECF-
2018-691] and the University of Warwick, through an Early Career Fellowship to
F.A.; the Engineering and Physical Sciences Research Council and the
Biotechnology and Biological Sciences Research Council [EP/L016494/1] are also
acknowledged for a scholarship to J.A.W. through the Centre for Doctoral Training in
Synthetic Biology (SynBioCDT).
References
Abraham, E. P., Newton, G. G. F., Crawford, K., Burton, H. S. and Hale, C. W.
(1953). Cephalosporin N: a new type of penicillin. Nature 171, 343. doi:10.1038/
171343a0
Agger, S., Lopez-Gallego, F. and Schmidt-Dannert, C. (2009). Diversity of
sesquiterpene synthases in the basidiomycete Coprinus cinereus.Mol. Microbiol.
72, 1181-1195. doi:10.1111/j.1365-2958.2009.06717.x
Alberti, F., Khairudin, K., Venegas, E. R., Davies, J. A., Hayes, P. M., Willis, C. L.,
Bailey, A. M. and Foster, G. D. (2017a). Heterologous expression reveals the
biosynthesis of the antibiotic pleuromutilin and generates bioactive semi-synthetic
derivatives. Nat. Commun. 8, 1831. doi:10.1038/s41467-017-01659-1
Alberti, F., Foster, G. D. and Bailey, A. M. (2017b). Natural products from
filamentous fungi and production by heterologous expression. Appl. Microbiol.
Biotechnol. 101, 493-500. doi:10.1007/s00253-016-8034-2
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990). Basic
local alignment search tool. J. Mol. Biol. 215, 403-410. doi:10.1016/S0022-
2836(05)80360-2
Andersson, C., Kristinsson, J. and Gry J. (2008) Occurrence and use of
hallucinogenic mushrooms containing psilocybin alkaloids. Nordic Council of
Ministers.
Anke, T., Hecht, H. J., Schramm, G. and Steglich, W. (1979). Antibiotics from
basidiomycetes. Ix Oudemansin, an antifungal antibiotic from Oudemansiella
mucida. J. Antibiot. 32, 1112. doi:10.7164/antibiotics.32.1112
Arnaud, M. B., Cerqueira, G. C., Inglis, D. O., Skrzypek, M. S., Binkley, J.,
Chibucos, M. C., Crabtree, J., Howarth, C., Orvis, J., Shah, P. et al. (2011). The
Aspergillus Genome Database (AspGD): recent developments in comprehensive
multispecies curation, comparative genomics and community resources. Nucleic
Acids Res. 40, D653-D659. doi:10.1093/nar/gkr875
Atli, B. and Yamac, M. (2012). Screening of medicinal higher basidiomycetes
mushrooms from Turkey for lovastatin production. Int. J. Med. Mushrooms 14,
149-159. doi:10.1615/IntJMedMushr.v14.i2.30
Bai, M.-S., Wang, C., Zong, S.-C., Lei, M. and Gao, J.-M. (2013). Antioxidant
polyketide phenolic metabolites from the edible mushroom Cortinarius
purpurascens. Food Chem. 141, 3424-3427. doi:10.1016/j.foodchem.2013.05.099
Bailey, A. M., Alberti, F., Kilaru, S., Collins, C. M., de Mattos-Shipley, K., Hartley,
A. J., Hayes, P., Griffin, A., Lazarus, C. M., Cox, R. J. et al. (2016). Identification
andmanipulation of the pleuromutilin gene cluster fromClitopilus passeckerianus for
increased rapid antibiotic production. Sci. Rep. 6, 25202. doi:10.1038/srep25202
Bartlett, D. W., Clough, J. M., Godwin, J. R., Hall, A. A., Hamer, M. and Parr-
Dobrzanski, B. (2002). The strobilurin fungicides. Pest Manag. Sci. 58, 649-662.
doi:10.1002/ps.520
Becker, W. F., Von Jagow, G., Anke, T. and Steglich, W. (1981). Oudemansin,
strobilurin A, strobilurin B and myxothiazol: new inhibitors of the bc1 segment of
the respiratory chain with an E-β-methoxyacrylate system as common structural
element. FEBS Lett. 132, 329-333. doi:10.1016/0014-5793(81)81190-8
Blin, K., Shaw, S., Steinke, K., Villebro, R., Ziemert, N., Lee, S. Y., Medema, M. H.
and Weber, T. (2019). antiSMASH 5.0: updates to the secondary metabolite
genomemining pipeline. Nucleic Acids Res. 47, W81-W87. doi:10.1093/nar/gkz310
Burns, C., Gregory, K. E., Kirby, M., Cheung, M. K., Riquelme, M., Elliott, T. J.,
Challen, M. P., Bailey, A. and Foster, G. D. (2005). Efficient GFP expression in
themushroomsAgaricus bisporus andCoprinus cinereus requires introns. Fungal
Genet. Biol. 42, 191-199. doi:10.1016/j.fgb.2004.11.005
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